A Cost-Effectiveness Analysis Of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine In Patients With Human Epidermal Growth Factor Receptor 2-Positive Unresectable Or Metastatic Breast Cancer In Portugal
AuthID
P-018-9X5
P-018-9X5